AU1191895A - Il-6 therapy - Google Patents

Il-6 therapy

Info

Publication number
AU1191895A
AU1191895A AU11918/95A AU1191895A AU1191895A AU 1191895 A AU1191895 A AU 1191895A AU 11918/95 A AU11918/95 A AU 11918/95A AU 1191895 A AU1191895 A AU 1191895A AU 1191895 A AU1191895 A AU 1191895A
Authority
AU
Australia
Prior art keywords
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU11918/95A
Inventor
Laurie A Myers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/166,564 external-priority patent/US5599536A/en
Priority claimed from US08/167,253 external-priority patent/US5578301A/en
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of AU1191895A publication Critical patent/AU1191895A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/204—IL-6

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU11918/95A 1993-12-13 1994-12-12 Il-6 therapy Abandoned AU1191895A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US166564 1993-12-13
US08/166,564 US5599536A (en) 1993-12-13 1993-12-13 Method for suppressing the acute phase response in a patient receiving IL-6 therapy
US08/167,253 US5578301A (en) 1993-12-14 1993-12-14 Method for using GM-CSF to reduce the acute phase response in a patient being administered IL-6 therapy
PCT/EP1994/004119 WO1995016458A1 (en) 1993-12-13 1994-12-12 Il-6 therapy
US167253 2002-06-11

Publications (1)

Publication Number Publication Date
AU1191895A true AU1191895A (en) 1995-07-03

Family

ID=26862359

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11918/95A Abandoned AU1191895A (en) 1993-12-13 1994-12-12 Il-6 therapy

Country Status (3)

Country Link
EP (1) EP0734265A1 (en)
AU (1) AU1191895A (en)
WO (1) WO1995016458A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6063372A (en) * 1995-10-27 2000-05-16 Inserm, Institut National De La Sante Et De La Recherche Medicale Uses of mammalian CTLA-8 and related reagents
CA2235951C (en) * 1995-10-27 2003-04-01 Schering Corporation Novel uses of mammalian ctla-8 and related reagents
US20090142294A1 (en) * 2005-01-25 2009-06-04 Apollo Life Sciences Limited Parameter selected gm-csf, il-3, il-4, il-5 and chimeras thereof for therapeutic and diagnostic purposes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2805224B2 (en) * 1989-01-13 1998-09-30 味の素株式会社 Antithrombotic agent

Also Published As

Publication number Publication date
EP0734265A1 (en) 1996-10-02
WO1995016458A1 (en) 1995-06-22

Similar Documents

Publication Publication Date Title
AU6623894A (en) Therapeutic compounds
AU7637694A (en) Controlled multi-pharmaceutical inhaler
AU4944093A (en) Osteosynthesis aid
AU4166393A (en) Auto-reclosers
AU1188395A (en) Infuser
AU1072695A (en) Dressing
AU3888793A (en) Novel medicament
AU3561193A (en) TNF-muteins
AU3991693A (en) Pyrazinoindoles
AU7961094A (en) Picosulphate dosage form
AU6092794A (en) Oxime-substituted therapeutic compounds
AU4177593A (en) Benzophenonehydrazones
AU3042892A (en) Rockbolt
AU6386390A (en) Therapeutic necleosides
AU667580B2 (en) Line-handling block
AU4156393A (en) Heterocyclyltriazolinones
AU664253B2 (en) Photo-deviometer
AU3562193A (en) Morpholin- and thiomorpholin-4-ylamides
AU3461693A (en) Saddle-cloth
GB9307013D0 (en) Therapeutic combinations
AU5737494A (en) Human thrombospondin-4
AU4164793A (en) Heterocyclyltriazolinones
AU2547895A (en) Therapeutic phenoxyalkylheterocycles
AU4632493A (en) Weathershed
AU1274295A (en) Heteroarylpyrroles